n=445 An RCT evaluating the acute and long-term safety and effectiveness of the DynamX Coronary Bioadaptor compared to contemporary drug-eluting stents. The study showed: 1.8% TLF at 12 months vs. 2.8% for DES 16% increase in blood flow -9% volume regression in lipid-rich lesions vs.
Discovery
Learnings
- auto_storiesStories
- categoryAreas
- helpFAQ
- forumConversations
- descriptionPapers
- mailNewsletters
- video_libraryVideos
- timelineTimeline
Guidance
- codeTechnology of APIs
- business_centerBusiness of APIs
- campaignEvangelism of APIs
- gavelGovernance of APIs
- historyHistory of APIs
- account_balancePolitics of APIs
Toolbox
- domainProviders
- apiAPIs
- cloudSolutions
- buildTools
- verifiedStandards
- gavelRegulations
- horizontal_ruleHeaders
- layersOverlays
- extensionExtensions
- schemaSchema
- policyPolicies
- ruleRules